摘要
目的探讨患者输血前进行血液病毒标志物检测的临床价值。方法抽取2014年4月至2015年4月我院接诊的864例输血患者作为研究对象,在输血前对所有患者进行血液病毒标志物检测,包括人类免疫缺陷病毒抗体(抗-HIV)、乙型肝炎病毒表面抗原(HBsAg)、梅毒螺旋体抗体(抗-TP)及丙型肝炎病毒抗体(抗-HCV),对检测结果进行分析。结果抗-HIV阳性检出率为0.00%,HBsAg阳性检出率为10.19%,抗-TP阳性检出率为0.81%,抗-HCV阳性检出率为0.93%,血液病毒标志物总阳性检出率为11.92%;男性患者抗-TP阳性、抗-HCV阳性检出率与女性患者比较,无明显差异(P>0.05);男性患者HBsAg阳性检出率显著高于女性患者(P<0.05)。结论在患者输血前对其进行血液病毒标志物检测,能及时掌握患者血液情况,降低传染性疾病传播风险,为患者生命健康提供保障。
Objective To discuss the clinical value of blood viral markers detection before blood transfusion. Methods Eight hundred and sixty-four patients with blood transfusion from April 2014 to April 2015 in our hospital were selected as the research objects. Before transfusion, all the patients were performed blood viral detection, including human immunodeficiency virus antibodies（anti-HIV）, hepatitis B virus surface antigen（HBsAg）, treponema pallidum antibody（anti-TP） and hepatitis C virus antibodies（anti-HCV）, then the testing results were analyzed. Results The positive detection rate of antiHIV, HBsAg, anti-TP and anti-HCV were 0.00%, 10.19%, 0.81% and 0.93% respectively, the total positive detection rate of blood virus markers was 11.92%. The positive detection rates of anti-TP and anti-HCV in the male patients were not significantly different from those in the female patients（P〈0.05）. The positive detection rate of HBsAg in the male patients was significantly higher than that in the female patients（P〈0.05）. Conclusion Performing blood viral markers detection before blood transfusion can grasp the situation of blood promptly, reduce the risk of infectious disease, and provide guarantee of patients＇ life and health.
出处
《临床医学研究与实践》
2017年第31期134-135,共2页
Clinical Research and Practice
关键词
输血前
血液病毒标志物
临床价值
before blood transfusion
blood viral markers detection
clinical value
